3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application(Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029

May 2024 | 454 pages | ID: 3FEDD7496F9EN
MarketsandMarkets

Abstracts

The 3D bioprinting market is projected to reach USD 2.4 Billion by 2029 from USD 1.3 Billion in 2024, at a CAGR of 12.7% during the forecast period. The 3D bioprinting market is driven by several key factors, including increasing collaborations between public and private entities and significant investments in research and development and growing interest in regenerative medicine and stem cell research.

“The 3D bioprinters segment held the dominant share in the 3D bioprinting market.”

Based on technology, the global 3D bioprinting market is segmented into 3D bioprinters, bioinks, software, and consumable. The 3D bioprinters is segmented into Microextrusion bioprinters, , inkjet 3D bioprinters, laser-assisted bioprinters, magnetic 3D bioprinters, stereolithography-based bioprinters, and other 3D bioprinters. The 3D bioprinters segment dominated the 3D bioprinting market in 2023. Advancements in 3D bioprinting technology and rising demand for organ transplants serves as driving factor in the 3D bioprinting market.

“Research application accounted for the largest share of the application in 2023.”

Based on application, the 3D bioprinting market is segmented into research application and clinical application. The research application is further segmented into regenerative medicine, 3D cell culture and drug research Also, the clinical application is segmented into bone & cartilage, blood vessels, skin and other clinical applications. In 2023, Research segment dominated the 3D bioprinting market. Research segment is anticipated to grow at significant CAGR during the forecast period of 2024-2028 owing to various factors such as biopharmaceuticals firms ramping up their utilization of 3D bioprinting technology.

“Asia Pacific region is likely to grow at a faster pace in the 3D bioprinting market.”

The 3D bioprinting market region is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and the Africa. The Asia-Pacific region is poised to experience significant growth in the 3D bioprinting market due to several key factors such as increasing healthcare expenditure in countries like China, India, and Southeast Asian nations region benefits from a significant population base and domestic system manufacturing, driving increased partnerships and collaborations aimed at healthcare improvement. With a high level of R&D intensity, market players are actively expanding their presence in the region, complemented by a surge in stem cell research, further stimulate market growth.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70%, and Demand Side - 30%
• By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, Middle East-and Africa -5%

List of Companies Profiled in the Report:

• BICO Group AB (Sweden)
• 3D Systems Inc. (US)
• Merck KGaA (Germany)
• Organovo Holdings Inc (US)
• Collplant Biotechnologies Ltd. (Israel)
• regenHU (Switzerland)
• Aspect Biosystem Ltd. (Canada)
• Advanced Solutions Life Sciences, llc (US)
• Cyfuse Biomedical K.K (Japan)
• Rokit Healthcare Inc (South Korea)
• Hangzhou Genofei Biotechnology Co., Ltd. (China)
• Foldink (Armenia)
• Brinter (US)
• 3D bioprinting solution (Russia).
• REGEMAT 3D, SL (Spain)
• ??ietis (France)
• Sunp Biotech (US)
• GeSim – Gesellschaft Fьr Silizium-Mikrosysteme Mbh (Germany)
• Medprin (China)
• Voxcell Bioinnovation Inc. (Canada)
• Prodways (France)
• Inventia Life Science Pty Ltd (Australia)
• Upnano Gmbh (Austria)
• UPM (Finland)
• Tissuelabs (Switzerland)

Research Coverage:

This report provides a detailed picture of the vaccine market. It aims at estimating the size and future growth potential of the market across different segments such as the components, material, application, end-user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D bioprinting market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancement in the 3D bioprinting , increasing number of public-private partnerships, rising investments in R&D and medical devices), opportunities (Rising demand for organ transplants and growing demand for regenerative medicine and stem cell research) and challenges (biocompatibility issues and rigorous sterilization protocols and ethical concerns related to the use of 3D bioprinted products) are influencing the growth of 3D bioprinting market.
• Product Development/Innovation: Detailed insights on newly launched products of the 3D bioprinting market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the 3D bioprinting market across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the 3D bioprinting market..
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players include BICO Group AB (Sweden), 3D Systems Inc. (US), Merck KGaA (Germany), Organovo Holdings Inc (US), Collplant Biotechnologies Ltd (Israel), regenHU (Switzerland), Aspect Biosystem (Canada), Advanced Solutions Life Sciences, llc (US), Cyfuse Biomedical K.K (Japan), Rokit Healthcare (South Korea), Hangzhou Genofei Biotechnology Co., Ltd. (China), Foldink (Armenia), Brinter (US) and 3D bioprinting solution (Russia).

Contents

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
  1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
  1.3.1 SEGMENTS COVERED
FIGURE 1 3D BIOPRINTING MARKET: SEGMENTS COVERED
  1.3.2 REGIONS COVERED
FIGURE 2 3D BIOPRINTING MARKET: REGIONS COVERED
  1.3.3 YEARS CONSIDERED
  1.3.4 CURRENCY CONSIDERED
1.4 RESEARCH LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
  1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
  2.1.1 SECONDARY DATA
  2.1.2 PRIMARY DATA
    2.1.2.1 Breakdown of primaries
FIGURE 4 BREAKDOWN OF PRIMARIES: 3D BIOPRINTING MARKET
2.2 MARKET SIZE ESTIMATION
FIGURE 5 3D BIOPRINTING MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2023
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023
FIGURE 7 ILLUSTRATIVE EXAMPLE OF BICO GROUP AB: REVENUE SHARE ANALYSIS (2023)
  2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 8 MARKET VALIDATION FROM PRIMARY SOURCES
  2.2.2 MARKET SIZE ESTIMATION, BY SEGMENT
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
  2.3.1 CAGR PROJECTIONS
FIGURE 10 3D BIOPRINTING MARKET: CAGR PROJECTIONS, 2024–2029
  2.3.2 IMPACT OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
2.4 STUDY ASSUMPTIONS
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.6 RISK ANALYSIS
2.7 IMPACT OF ECONOMIC RECESSION ON 3D BIOPRINTING MARKET

3 EXECUTIVE SUMMARY

FIGURE 12 3D BIOPRINTING MARKET, BY COMPONENT 2024 VS. 2029 (USD MILLION)
FIGURE 13 3D BIOPRINTING MARKET, BY APPLICATION, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 14 3D BIOPRINTING MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION)
FIGURE 15 3D BIOPRINTING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF 3D BIOPRINTING MARKET

4 PREMIUM INSIGHTS

4.1 3D BIOPRINTING MARKET OVERVIEW
FIGURE 17 RISING DEMAND FOR ORGAN TRANSPLANTS TO DRIVE MARKET
4.2 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT AND COUNTRY (2023)
FIGURE 18 US AND 3D BIOPRINTERS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.3 3D BIOPRINTING MARKET, BY COMPONENT, 2024 VS. 2029
FIGURE 19 3D BIOPRINTERS TO DOMINATE MARKET DURING STUDY PERIOD
4.4 3D BIOPRINTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  5.2.1 DRIVERS
    5.2.1.1 Growing adoption of 3D bioprinting in pharmaceutical and cosmetic industries
    5.2.1.2 Technological advancements in 3D bioprinting
    5.2.1.3 Increasing number of public-private partnerships
    5.2.1.4 Rising investments in medical device R&D
  5.2.2 RESTRAINTS
    5.2.2.1 Risk of 3D bioprinting failures
    5.2.2.2 High cost of 3D bioprinters and bioinks
  5.2.3 OPPORTUNITIES
    5.2.3.1 Rising demand for organ transplants
FIGURE 22 NUMBER OF ORGAN TRANSPLANTS IN US (2024)
    5.2.3.2 Growing demand for regenerative medicine and stem cell research
  5.2.4 CHALLENGES
    5.2.4.1 Biocompatibility issues and rigorous sterilization protocols
    5.2.4.2 Ethical concerns related to use of 3D-bioprinted products
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 23 REVENUE SHIFT TOWARDS 3D BIOPRINTING COMPANIES
5.4 TECHNOLOGY ANALYSIS
  5.4.1 KEY TECHNOLOGIES
    5.4.1.1 Extrusion-based bioprinting
    5.4.1.2 Inkjet-based bioprinting
    5.4.1.3 Stereolithography bioprinting
  5.4.2 COMPLEMENTARY TECHNOLOGIES
    5.4.2.1 Microfluidics and microfabrication
    5.4.2.2 Nanotechnology and nanomaterials
  5.4.3 ADJACENT TECHNOLOGIES
    5.4.3.1 3D scanning and imaging
    5.4.3.2 Organ-on-a-chip
    5.4.3.3 Organoids technology
5.5 PRICING ANALYSIS
  5.5.1 AVERAGE SELLING PRICE OF COMPONENTS, BY REGION
TABLE 2 3D BIOPRINTING MARKET: AVERAGE SELLING PRICE OF COMPONENTS, BY REGION, 2021–2023
5.6 VALUE CHAIN ANALYSIS
FIGURE 24 3D BIOPRINTING MARKET: VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 25 3D BIOPRINTING MARKET: SUPPLY CHAIN ANALYSIS
TABLE 3 3D BIOPRINTING MARKET: ROLE IN SUPPLY CHAIN
5.8 ECOSYSTEM ANALYSIS
FIGURE 26 3D BIOPRINTING MARKET: ECOSYSTEM MAP
  5.8.1 3D BIOPRINTER VENDORS
TABLE 4 3D BIOPRINTER VENDORS: ROLE IN ECOSYSTEM
  5.8.2 BIOINK VENDORS
TABLE 5 BIOINK VENDORS: ROLE IN ECOSYSTEM
  5.8.3 END USERS
TABLE 6 END USERS: ROLE IN ECOSYSTEM
  5.8.4 REGULATORY BODIES
TABLE 7 REGULATORY BODIES: ROLE IN ECOSYSTEM
5.9 PATENT ANALYSIS
  5.9.1 METHODOLOGY
  5.9.2 NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2014–2024
TABLE 8 NUMBER OF PATENTS APPLIED AND GRANTED, 2014–2024
  5.9.3 INNOVATION AND PATENT APPLICATION
FIGURE 27 NUMBER OF PATENTS GRANTED ANNUALLY, 2014–2024
  5.9.4 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS
FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024
FIGURE 29 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024
TABLE 9 3D BIOPRINTING MARKET: TOP 12 PATENT OWNERS IN US, 2014–2024
TABLE 10 PATENTS IN 3D BIOPRINTING MARKET, 2023
5.10 TRADE ANALYSIS
  5.10.1 IMPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351)
TABLE 11 IMPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019–2023 (TONS)
  5.10.2 EXPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351)
TABLE 12 EXPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019–2023 (TONS)
  5.10.3 IMPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339)
TABLE 13 IMPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339), 2019–2023 (USD)
  5.10.4 EXPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339)
TABLE 14 EXPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE-844339), 2019–2023 (USD)
5.11 KEY CONFERENCES AND EVENTS, 2024–2025
TABLE 15 3D BIOPRINTING MARKET: KEY CONFERENCES AND EVENTS
5.12 REGULATORY LANDSCAPE
  5.12.1 CDRH REGULATIONS ON 3D BIOPRINTING
  5.12.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 INVESTMENT AND FUNDING SCENARIO
5.14 PORTER’S FIVE FORCES ANALYSIS
FIGURE 30 3D BIOPRINTING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 20 3D BIOPRINTING MARKET: PORTER’S FIVE FORCES ANALYSIS
  5.14.1 THREAT OF NEW ENTRANTS
  5.14.2 THREAT OF SUBSTITUTES
  5.14.3 BARGAINING POWER OF BUYERS
  5.14.4 BARGAINING POWER OF SUPPLIERS
  5.14.5 INTENSITY OF COMPETITIVE RIVALRY
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
  5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  5.15.2 KEY BUYING CRITERIA
    5.15.2.1 Key buying criteria for top three end users
TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS IN 3D BIOPRINTERS MARKET

6 3D BIOPRINTING MARKET, BY COMPONENT

6.1 INTRODUCTION
TABLE 23 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
6.2 3D BIOPRINTERS
TABLE 24 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 25 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 26 NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 27 EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 28 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  6.2.1 MICRO EXTRUSION BIOPRINTERS
    6.2.1.1 Adaptability to different biomaterial types to fuel segment growth
TABLE 32 MICRO EXTRUSION BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 33 NORTH AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 EUROPE: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 ASIA PACIFIC: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 LATIN AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 MIDDLE EAST: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 GCC COUNTRIES: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  6.2.2 INKJET 3D BIOPRINTERS
    6.2.2.1 High cell viability and low cost to propel market growth
TABLE 39 INKJET 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 40 NORTH AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 EUROPE: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 ASIA PACIFIC: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 LATIN AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44 MIDDLE EAST: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 GCC COUNTRIES: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  6.2.3 LASER-ASSISTED BIOPRINTERS
    6.2.3.1 Higher resolution and better formation of 3D structures to augment segment growth
TABLE 46 LASER-ASSISTED BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 47 NORTH AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 EUROPE: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 ASIA PACIFIC: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 LATIN AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 51 MIDDLE EAST: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 GCC COUNTRIES: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  6.2.4 STEREOLITHOGRAPHY-BASED BIOPRINTERS
    6.2.4.1 Better printing quality, speed, and cell viability to aid growth
TABLE 53 STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 54 NORTH AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 EUROPE: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 ASIA PACIFIC: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 LATIN AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 MIDDLE EAST: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 GCC COUNTRIES: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  6.2.5 MAGNETIC 3D BIOPRINTERS
    6.2.5.1 Improved accuracy and speed in cultured tissue formation and processing to fuel segment growth
TABLE 60 MAGNETIC 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 61 NORTH AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 EUROPE: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 ASIA PACIFIC: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 LATIN AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 MIDDLE EAST: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 GCC COUNTRIES: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  6.2.6 OTHER 3D BIOPRINTERS
TABLE 67 OTHER 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 68 NORTH AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 69 EUROPE: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 ASIA PACIFIC: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71 LATIN AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 72 MIDDLE EAST: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 73 GCC COUNTRIES: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3 BIOINKS
TABLE 74 3D BIOPRINTERS MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 75 3D BIOPRINTING MARKET FOR BIOINKS, BY REGION, 2022–2029 (USD MILLION)
TABLE 76 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 80 MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 81 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
  6.3.1 NATURAL BIOINKS
    6.3.1.1 Increasing investment in R&D and product developments to drive market
TABLE 82 NATURAL BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 83 NORTH AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 EUROPE: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 ASIA PACIFIC: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 LATIN AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 87 MIDDLE EAST: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 GCC COUNTRIES: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  6.3.2 HYBRID BIOINKS
    6.3.2.1 Higher mechanical strength and greater biocompatibility to boost segment growth
TABLE 89 HYBRID BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 EUROPE: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 92 ASIA PACIFIC: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 LATIN AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 94 MIDDLE EAST: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 GCC COUNTRIES: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  6.3.3 SYNTHETIC BIOINKS
    6.3.3.1 Flexibility, control, and consistency to aid segment growth
TABLE 96 SYNTHETIC BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 97 NORTH AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 EUROPE: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 99 ASIA PACIFIC: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 100 LATIN AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 101 MIDDLE EAST: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 GCC COUNTRIES: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.4 SOFTWARE
  6.4.1 INCREASING INNOVATIONS AND ADVANCEMENTS TO PROPEL SEGMENT GROWTH
TABLE 103 3D BIOPRINTING MARKET FOR SOFTWARE, BY REGION, 2022–2029 (USD MILLION)
TABLE 104 NORTH AMERICA: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 EUROPE: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 107 LATIN AMERICA: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 MIDDLE EAST: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
6.5 CONSUMABLES
  6.5.1 NEED FOR PRECISE BIOINK DEPOSITION FOR INTRICATE TISSUE STRUCTURES TO DRIVE MARKET
TABLE 110 3D BIOPRINTING MARKET FOR CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 111 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 EUROPE: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)

7 3D BIOPRINTING MARKET, BY MATERIAL

7.1 INTRODUCTION
TABLE 117 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
7.2 LIVING CELLS
  7.2.1 INCREASED VIABILITY AND TECHNOLOGICAL ADVANCEMENTS TO AUGMENT MARKET GROWTH
TABLE 118 3D BIOPRINTING MARKET FOR LIVING CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 119 NORTH AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 120 EUROPE: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 LATIN AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 MIDDLE EAST: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
7.3 HYDROGELS
  7.3.1 INCREASING INVESTMENTS AND FUNDING TO BOOST MARKET GROWTH
TABLE 125 3D BIOPRINTING MARKET FOR HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
TABLE 126 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 EUROPE: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 LATIN AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 130 MIDDLE EAST: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
7.4 EXTRACELLULAR MATRICES
  7.4.1 INCREASED FOCUS ON R&D AND ADVANCEMENTS IN TISSUE ENGINEERING TO SUPPORT MARKET GROWTH
TABLE 132 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2022–2029 (USD MILLION)
TABLE 133 NORTH AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 EUROPE: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 LATIN AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 MIDDLE EAST: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 138 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
7.5 OTHER MATERIALS
TABLE 139 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY REGION, 2022–2029 (USD MILLION)
TABLE 140 NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 EUROPE: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 LATIN AMERICA: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 144 MIDDLE EAST: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)

8 3D BIOPRINTING MARKET, BY APPLICATION

8.1 INTRODUCTION
TABLE 146 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
8.2 RESEARCH APPLICATIONS
TABLE 147 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 148 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 149 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  8.2.1 DRUG RESEARCH
    8.2.1.1 Better precision and greater customization facilities in pharmaceutical sector to drive segment
TABLE 155 DRUG RESEARCH MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 156 NORTH AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 157 EUROPE: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 ASIA PACIFIC: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 LATIN AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 MIDDLE EAST: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161 GCC COUNTRIES: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  8.2.2 REGENERATIVE MEDICINE
    8.2.2.1 Growing demand for organ transplants to support segment growth
TABLE 162 REGENERATIVE MEDICINE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 163 NORTH AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 164 EUROPE: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 ASIA PACIFIC: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 LATIN AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 MIDDLE EAST: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 GCC COUNTRIES: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  8.2.3 3D CELL CULTURE
    8.2.3.1 Rising investments in cell culture development to augment segment growth
TABLE 169 3D CELL CULTURE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 170 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 171 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 172 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 LATIN AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 MIDDLE EAST: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
8.3 CLINICAL APPLICATIONS
TABLE 176 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 177 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 178 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  8.3.1 SKIN
    8.3.1.1 Rising applications in skincare and cosmetics to propel segment growth
TABLE 184 SKIN MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 185 NORTH AMERICA: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 186 EUROPE: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187 ASIA PACIFIC: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188 LATIN AMERICA: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 MIDDLE EAST: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 GCC COUNTRIES: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  8.3.2 BONE & CARTILAGE
    8.3.2.1 Increasing incidence of musculoskeletal conditions to support segment growth
TABLE 191 BONE & CARTILAGE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 192 NORTH AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 193 EUROPE: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 ASIA PACIFIC: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 LATIN AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 MIDDLE EAST: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 GCC COUNTRIES: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  8.3.3 BLOOD VESSELS
    8.3.3.1 Growing focus on research activities to aid segment growth
TABLE 198 BLOOD VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 199 NORTH AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 200 EUROPE: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 201 ASIA PACIFIC: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 LATIN AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 MIDDLE EAST: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 GCC COUNTRIES: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  8.3.4 OTHER CLINICAL APPLICATIONS
TABLE 205 OTHER CLINICAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 206 NORTH AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 207 EUROPE: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 208 ASIA PACIFIC: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 LATIN AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210 MIDDLE EAST: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 211 GCC COUNTRIES: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

9 3D BIOPRINTING MARKET, BY END USER

9.1 INTRODUCTION
TABLE 212 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2 ACADEMIC & RESEARCH INSTITUTES
  9.2.1 RISING GOVERNMENT FUNDING AND INCREASING NUMBER OF INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET
TABLE 213 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 214 NORTH AMERICA: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 215 EUROPE: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217 LATIN AMERICA: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 MIDDLE EAST: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  9.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET GROWTH
TABLE 220 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 221 NORTH AMERICA: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 222 EUROPE: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224 LATIN AMERICA: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 MIDDLE EAST: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 226 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
9.4 HOSPITALS
  9.4.1 RISING NUMBER OF STRATEGIC PARTNERSHIPS WITH BIOTECHNOLOGY COMPANIES TO AID MARKET GROWTH
TABLE 227 3D BIOPRINTING MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
TABLE 228 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 229 EUROPE: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231 LATIN AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 MIDDLE EAST: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)

10 3D BIOPRINTING MARKET, BY REGION

10.1 INTRODUCTION
TABLE 234 3D BIOPRINTING MARKET, BY REGION, 2022–2029 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 31 NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT
TABLE 235 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 236 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 237 NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 238 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 239 NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 240 NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 241 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 242 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 243 NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.2.1 NORTH AMERICA: RECESSION IMPACT
  10.2.2 US
    10.2.2.1 US to dominate North American 3D bioprinting market during forecast period
TABLE 244 US: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 245 US: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 246 US: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 247 US: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 248 US: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 249 US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 250 US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 251 US: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.2.3 CANADA
    10.2.3.1 Increased number of public-private partnerships for life science research to drive market
TABLE 252 CANADA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 253 CANADA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 254 CANADA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 255 CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 256 CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 257 CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 258 CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 259 CANADA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3 EUROPE
TABLE 260 EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 261 EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 262 EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 263 EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 264 EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 265 EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 266 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 267 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 268 EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.3.1 EUROPE: RECESSION IMPACT
  10.3.2 GERMANY
    10.3.2.1 Rising healthcare expenditure and increasing demand for organ transplants to favor market growth
TABLE 269 GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 270 GERMANY: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 271 GERMANY: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 272 GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 273 GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 274 GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 275 GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 276 GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.3.3 UK
    10.3.3.1 Rising prevalence of chronic diseases and increasing R&D activities to drive market
TABLE 277 UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 278 UK: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 279 UK: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 280 UK: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 281 UK: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 282 UK: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 283 UK: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 284 UK: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.3.4 FRANCE
    10.3.4.1 Increasing availability of advanced medical technologies to support market growth
TABLE 285 FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 286 FRANCE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 287 FRANCE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 288 FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 289 FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 290 FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 291 FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 292 FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.3.5 ITALY
    10.3.5.1 Increased research investment and funding to support market growth
TABLE 293 ITALY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 294 ITALY: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 295 ITALY: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 296 ITALY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 297 ITALY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 298 ITALY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 299 ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 300 ITALY: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.3.6 SPAIN
    10.3.6.1 Favorable investment scenario and increase in number of research centers to aid market growth
TABLE 301 SPAIN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 302 SPAIN: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 303 SPAIN: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 304 SPAIN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 305 SPAIN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 306 SPAIN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 307 SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 308 SPAIN: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.3.7 REST OF EUROPE
TABLE 309 REST OF EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 310 REST OF EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 311 REST OF EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 312 REST OF EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 313 REST OF EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 314 REST OF EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 315 REST OF EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 316 REST OF EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 32 ASIA PACIFIC: 3D BIOPRINTING MARKET SNAPSHOT
TABLE 317 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 318 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 319 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 320 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 321 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 322 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 323 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 324 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 325 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.4.1 CHINA
    10.4.1.1 Increasing government focus on pharmaceutical R&D and growing demand for organ transplants to augment market growth
TABLE 326 CHINA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 327 CHINA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 328 CHINA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 329 CHINA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 330 CHINA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 331 CHINA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 332 CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 333 CHINA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.4.2 JAPAN
    10.4.2.1 Advancements in healthcare infrastructure to support market growth
TABLE 334 JAPAN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 335 JAPAN: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 336 JAPAN: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 337 JAPAN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 338 JAPAN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 339 JAPAN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 340 JAPAN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 341 JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.4.3 INDIA
    10.4.3.1 Increasing developments in biopharmaceutical industry to propel market growth
TABLE 342 INDIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 343 INDIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 344 INDIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 345 INDIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 346 INDIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 347 INDIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 348 INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 349 INDIA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.4.4 AUSTRALIA
    10.4.4.1 Rising private and public funding for research activities to drive market
TABLE 350 AUSTRALIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 351 AUSTRALIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 352 AUSTRALIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 353 AUSTRALIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 354 AUSTRALIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 355 AUSTRALIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 356 AUSTRALIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 357 AUSTRALIA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.4.5 SOUTH KOREA
    10.4.5.1 Favorable government policies and high investments from private sector to fuel market growth
TABLE 358 SOUTH KOREA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 359 SOUTH KOREA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 360 SOUTH KOREA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 361 SOUTH KOREA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 362 SOUTH KOREA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 363 SOUTH KOREA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 364 SOUTH KOREA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 365 SOUTH KOREA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.4.6 REST OF ASIA PACIFIC
  10.4.7 ASIA PACIFIC: RECESSION IMPACT
TABLE 366 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 367 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 368 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 369 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 370 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 371 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 372 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 373 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.5 LATIN AMERICA
TABLE 374 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 375 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 376 LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 377 LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 378 LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 379 LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 380 LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 381 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 382 LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.5.1 LATIN AMERICA: RECESSION IMPACT
  10.5.2 BRAZIL
    10.5.2.1 Brazil to hold largest share in Latin American market
TABLE 383 BRAZIL: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 384 BRAZIL: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 385 BRAZIL: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 386 BRAZIL: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 387 BRAZIL: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 388 BRAZIL: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 389 BRAZIL: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 390 BRAZIL: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.5.3 MEXICO
    10.5.3.1 Increasing incidence of diabetes and growing geriatric population to aid market growth
TABLE 391 MEXICO: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 392 MEXICO: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 393 MEXICO: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 394 MEXICO: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 395 MEXICO: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 396 MEXICO: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 397 MEXICO: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 398 MEXICO: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.5.4 REST OF LATIN AMERICA
TABLE 399 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 400 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 401 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 402 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 403 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 404 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 405 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 406 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.6 MIDDLE EAST
TABLE 407 MIDDLE EAST: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 408 MIDDLE EAST: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 409 MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 410 MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 411 MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 412 MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 413 MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 414 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 415 MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.6.1 MIDDLE EAST: RECESSION IMPACT
  10.6.2 GCC COUNTRIES
TABLE 416 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 417 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 418 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 419 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 420 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 421 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 422 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 423 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 424 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
    10.6.2.1 Saudi Arabia
      10.6.2.1.1 Increasing government investments in healthcare and growing pharmaceuticals industry to support market growth
TABLE 425 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 426 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 427 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 428 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 429 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 430 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 431 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 432 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
    10.6.2.2 United Arab Emirates
      10.6.2.2.1 Increased R&D expenditure and advanced healthcare infrastructure to boost market growth
TABLE 433 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 434 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 435 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 436 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 437 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 438 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 439 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 440 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
    10.6.2.3 Rest of GCC countries
TABLE 441 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 442 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 443 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 444 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 445 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 446 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 447 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 448 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.6.3 REST OF MIDDLE EAST
TABLE 449 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 450 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 451 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 452 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 453 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 454 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 455 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 456 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.7 AFRICA
  10.7.1 GROWING FOCUS ON FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO AID MARKET GROWTH
TABLE 457 AFRICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 458 AFRICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 459 AFRICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 460 AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
TABLE 461 AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 462 AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 463 AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 464 AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  10.7.2 AFRICA: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 KEY STRATEGIES/RIGHT TO WIN
FIGURE 33 3D BIOPRINTING MARKET: STRATEGIES ADOPTED
11.3 REVENUE ANALYSIS
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS (2021–2023)
11.4 MARKET SHARE ANALYSIS
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
TABLE 465 3D BIOPRINTING MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  11.5.1 STARS
  11.5.2 EMERGING LEADERS
  11.5.3 PERVASIVE PLAYERS
  11.5.4 PARTICIPANTS
FIGURE 36 3D BIOPRINTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    11.5.5.1 Overall footprint
FIGURE 37 3D BIOPRINTING MARKET: OVERALL FOOTPRINT
    11.5.5.2 Component footprint
TABLE 466 3D BIOPRINTING MARKET: COMPONENT FOOTPRINT
    11.5.5.3 Regional footprint
TABLE 467 3D BIOPRINTING MARKET: REGIONAL FOOTPRINT
    11.5.5.4 Material footprint
TABLE 468 3D BIOPRINTING MARKET: MATERIAL FOOTPRINT
    11.5.5.5 Application footprint
TABLE 469 3D BIOPRINTING MARKET: APPLICATION FOOTPRINT
11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
  11.6.1 PROGRESSIVE COMPANIES
  11.6.2 RESPONSIVE COMPANIES
  11.6.3 DYNAMIC COMPANIES
  11.6.4 STARTING BLOCKS
FIGURE 38 3D BIOPRINTING MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
TABLE 470 3D BIOPRINTING MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 471 3D BIOPRINTING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
11.7 VALUATION AND FINANCIAL METRICS
FIGURE 39 EV/EBITDA OF KEY VENDORS
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
11.8 BRAND/PRODUCT COMPARISON
FIGURE 41 3D BIOPRINTING MARKET: BRAND/PRODUCT COMPARISON
  11.8.1 BICO GROUP AB
  11.8.2 REGENHU
  11.8.3 ROKIT HEALTHCARE, INC.
11.9 COMPETITIVE SCENARIO
  11.9.1 PRODUCT LAUNCHES
TABLE 472 3D BIOPRINTING MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
  11.9.2 DEALS
TABLE 473 3D BIOPRINTING MARKET: DEALS, JANUARY 2021–MARCH 2024
  11.9.3 EXPANSIONS
TABLE 474 3D BIOPRINTING MARKET: EXPANSIONS, JANUARY 2021–MARCH 2024
  11.9.4 OTHER DEVELOPMENTS
TABLE 475 3D BIOPRINTING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024

12 COMPANY PROFILES

(Business overview, Products/Solutions/Services offered, Recent developments & MnM View)*
12.1 KEY PLAYERS
  12.1.1 BICO GROUP AB
TABLE 476 BICO GROUP AB: COMPANY OVERVIEW
FIGURE 42 BICO GROUP AB: COMPANY SNAPSHOT (2023)
TABLE 477 BICO GROUP AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 478 BICO GROUP AB: PRODUCT LAUNCHES
TABLE 479 BICO GROUP AB: DEALS
TABLE 480 BICO GROUP AB: EXPANSIONS
TABLE 481 BICO GROUP AB: OTHER DEVELOPMENTS
  12.1.2 3D SYSTEMS, INC.
TABLE 482 3D SYSTEMS, INC.: COMPANY OVERVIEW
FIGURE 43 3D SYSTEMS, INC.: COMPANY SNAPSHOT (2022)
TABLE 483 3D SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 484 3D SYSTEMS, INC.: DEALS
TABLE 485 3D SYSTEMS, INC.: EXPANSIONS
  12.1.3 MERCK KGAA
TABLE 486 MERCK KGAA: COMPANY OVERVIEW
FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2023)
TABLE 487 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 488 MERCK KGAA: EXPANSIONS
  12.1.4 ORGANOVO HOLDINGS INC.
TABLE 489 ORGANOVO HOLDINGS INC.: COMPANY OVERVIEW
FIGURE 45 ORGANOVO HOLDINGS INC.: COMPANY SNAPSHOT (2023)
TABLE 490 ORGANOVO HOLDINGS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 491 ORGANOVO HOLDINGS INC.: DEALS
  12.1.5 COLLPLANT BIOTECHNOLOGIES LTD.
TABLE 492 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW
FIGURE 46 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT (2023)
TABLE 493 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 494 COLLPLANT BIOTECHNOLOGIES LTD.: PIPELINE PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 495 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCT LAUNCHES
TABLE 496 COLLPLANT BIOTECHNOLOGIES LTD.: DEALS
  12.1.6 REGENHU
TABLE 497 REGENHU: COMPANY OVERVIEW
TABLE 498 REGENHU: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  12.1.7 ASPECT BIOSYSTEMS LTD.
TABLE 499 ASPECT BIOSYSTEMS LTD.: COMPANY OVERVIEW
TABLE 500 ASPECT BIOSYSTEMS LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 501 ASPECT BIOSYSTEMS LTD.: DEALS
  12.1.8 ADVANCED SOLUTIONS LIFE SCIENCES, LLC
TABLE 502 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: COMPANY OVERVIEW
TABLE 503 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 504 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: DEALS
TABLE 505 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: OTHER DEVELOPMENTS
  12.1.9 CYFUSE BIOMEDICAL K.K.
TABLE 506 CYFUSE BIOMEDICAL K.K.: COMPANY OVERVIEW
TABLE 507 CYFUSE BIOMEDICAL K.K.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  12.1.10 ROKIT HEALTHCARE, INC.
TABLE 508 ROKIT HEALTHCARE, INC.: COMPANY OVERVIEW
TABLE 509 ROKIT HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  12.1.11 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.
TABLE 510 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 511 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  12.1.12 FOLDINK
TABLE 512 FOLDINK: COMPANY OVERVIEW
TABLE 513 FOLDINK: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  12.1.13 BRINTER
TABLE 514 BRINTER: COMPANY OVERVIEW
TABLE 515 BRINTER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 516 BRINTER: DEALS
TABLE 517 BRINTER: EXPANSIONS
  12.1.14 3D BIOPRINTING SOLUTIONS
TABLE 518 3D BIOPRINTING SOLUTIONS: COMPANY OVERVIEW
TABLE 519 3D BIOPRINTING SOLUTIONS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
*Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
  12.2.1 REGEMAT 3D, SL
TABLE 520 REGEMAT 3D, SL: COMPANY OVERVIEW
  12.2.2 ????TIS
TABLE 521 POIETIS: COMPANY OVERVIEW
  12.2.3 SUNP BIOTECH
TABLE 522 SUNP BIOTECH: COMPANY OVERVIEW
  12.2.4 GESIM–GESELLSCHAFT FЬR SILIZIUM-MIKROSYSTEME MBH
TABLE 523 GESIM–GESELLSCHAFT FЬR SILIZIUM-MIKROSYSTEME MBH: COMPANY OVERVIEW
  12.2.5 MEDPRIN
TABLE 524 MEDPRIN: COMPANY OVERVIEW
  12.2.6 VOXCELL BIOINNOVATION INC.
TABLE 525 VOXCELL BIOINNOVATION INC.: COMPANY OVERVIEW
  12.2.7 PRODWAYS
TABLE 526 PRODWAYS: COMPANY OVERVIEW
  12.2.8 INVENTIA LIFE SCIENCE PTY LTD.
TABLE 527 INVENTIA LIFE SCIENCE PTY LTD.: COMPANY OVERVIEW
  12.2.9 UPNANO GMBH
TABLE 528 UPNANO GMBH: COMPANY OVERVIEW
  12.2.10 UPM
TABLE 529 UPM: COMPANY OVERVIEW
  12.2.11 TISSUELABS
TABLE 530 TISSUELABS: COMPANY OVERVIEW

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS